Shares of Kodiak Sciences (NASDAQ: KOD) experienced a notable increase on Thursday, rising following an upgrade from Barclays. The investment bank cited encouraging data from a...
Ideaya Biosciences has received new coverage from both Barclays and Citizens, indicating a growing confidence in the company’s oncology pipeline. This development comes as Ideaya aims...